SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

As U.S. pharma braces for a $236B patent cliff, Chinese biotech surges—and EquitiesFirst unlocks capital with equity-backed ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro.

ON Trump’s doorstep, civilians have been urged to “take up arms” against the United States after a wave of strikes on drug ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

The music mogul’s lawyers said in a filing that their incarcerated client deserves to be let go soon after his Oct. 3 ...

Fukuoka, Japan - September 26, 2025 - Tres Alchemix, an early-stage biotechnology company applying artificial intelligence (AI) to drug discovery, today announced it has closed a $4.4 million [¥650 ...

Researchers at Baylor College of Medicine have developed a powerful new data analysis method named COOKIE-Pro (Covalent Occupancy Kinetic Enrichment ...

There’s a good chance you can get your IRMAA eliminated or reduced if your income has dropped in the past two years.

If the CEO of Astronomer had overseen tax fraud instead of being caught on a kiss cam cuddling his HR chief in an ...